The clinical utility and epidemiological impact of self-testing for SARS-CoV-2 using antigen detecting diagnostics: a systematic review and meta-analysis

Author:

Brümmer Lukas E.ORCID,Erdmann ChristianORCID,Tolle Hannah,McGrath SeanORCID,Olaru Ioana D.ORCID,Katzenschlager StephanORCID,Yerlikaya SedaORCID,Grilli MaurizioORCID,Pollock Nira R.ORCID,Erkosar BerraORCID,Mace AurelienORCID,Ongarello StefanoORCID,Johnson Cheryl C.ORCID,Sacks Jilian A.ORCID,Denkinger Claudia M.ORCID

Abstract

ABSTRACTIntroductionSelf-testing for COVID-19 (C19ST) based on antigen detecting diagnostics could significantly support controlling the SARS-CoV-2 pandemic. To inform the World Health Organization in developing a C19ST guideline, we performed a systematic review and meta-analysis of the available literature.MethodsWe electronically searched Medline and the Web of Science core collection, performed secondary reference screening, and contacted experts for further relevant publications. Any study published between December 1, 2020 and November 30, 2021 assessing the epidemiological impact and clinical utility of C19ST was included. Study quality was evaluated using the Newcastle Ottawa Scale (NOS). The review was registered on PROSPERO (CRD42022299977).Results11 studies only from high-income countries with an overall low quality (median of 3/9 stars on the NOS) were found. Pooled C19ST positivity was 0.2% (95% CI 0.1% to 0.4%; eight data sets) in populations where otherwise no dedicated testing would have occurred. The impact of self-testing on virus transmission was uncertain. Positive test results mainly resulted in people having to isolate without further confirmation of results (eight data sets). When testing was voluntary by study design, pooled testing uptake was 53.2% (95% CI 36.7% to 68.9%; five data sets. Outside direct health impacts, C19ST reduced quarantine duration and absenteeism from work, and made study participants feel safer. Study participants favored self-testing and were confident that they performed testing and sampling correctly.ConclusionsThe present data suggests that C19ST could be a valuable tool in reducing the spread of COVID-19, as it can achieve good uptake, may identify additional cases, and was generally perceived as positive by study participants. However, data was very limited and heterogenous, and further research especially in low- and middle-income countries is needed to assess the clinical utility and epidemiological impact of C19ST in more detail.CONTRIBUTIONS TO THE LITERATURE- COVID-19 self-testing (C19ST) using antigen detection could conceivably support pandemic control. A current PubMed search found no systematic evidence synthesis of studies assessing the epidemiological impact and clinical utility of C19ST implementation- We systematically reviewed and meta-analyzed 11 studies including more than 1.1 million persons tested- C19ST can achieve good uptake, may identify additional cases, and was general perceived as positive by study participants, suggesting it to be a valuable tool in reducing the spread of SARS-CoV-2- Further data especially from low- and middle-income countries is needed to understand the impact of C19ST in more detail

Publisher

Cold Spring Harbor Laboratory

Reference47 articles.

1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 -16 March 2020. 2020.

2. World Health Organization. COVID-19 strategic preparedness and response plan. 2021.

3. Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data

4. Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies

5. Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3